» Articles » PMID: 28932970

Computed Tomography Features of the Major Salivary Glands After Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma

Overview
Journal Radiol Med
Specialty Radiology
Date 2017 Sep 22
PMID 28932970
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: No previous study has investigated computed tomography (CT) features of the major salivary glands (MSGs) after postoperative radioactive iodine ablation (RIA). This study aimed to assess CT features of the MSGs after RIA in patients with papillary thyroid carcinoma (PTC).

Methods: The study population comprised consecutively registered PTC patients who had undergone total thyroidectomy, RIA, follow-up neck ultrasonography (US), and neck CT. The US and CT features of the parotid and submandibular glands in each patient were retrospectively evaluated by a single radiologist. Post-RIA changes were determined by comparisons between follow-up neck US results (main reference) and between preoperative and post-RIA neck CT features.

Results: Of the 28 patients, 13 (46.4%) showed post-RIA changes in the parotid glands (n = 8), submandibular glands (n = 0), or both (n = 5) on neck CT. Of the 56 MSGs in 28 patients, post-RIA changes were more common in the parotid glands (n = 23, 41.1%) than in the submandibular glands (n = 8, 14.3%). The common CT findings of post-RIA changes in the parotid gland included low parenchymal attenuation, decreased glandular size, a lobulated margin, decreased or increased parenchymal enhancement, and an inhomogeneous enhancement pattern, whereas common CT findings of post-RIA changes in the submandibular gland included decreased glandular size, a lobulated margin, iso-enhancement, and an inhomogeneous enhancement pattern.

Conclusion: The common CT features of post-RIA changes in MSGs include decreased glandular size, a lobulated margin, and an inhomogeneous enhancement pattern.

Citing Articles

Narrative review of multiparametric ultrasound in parotid gland evaluation.

Martino M, Fodor D, Fresilli D, Guiban O, Rubini A, Cassoni A Gland Surg. 2021; 9(6):2295-2311.

PMID: 33447581 PMC: 7804540. DOI: 10.21037/gs-20-530.


Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis.

Gentili F, Guerrini S, Mazzei F, Monteleone I, Di Meglio N, Sansotta L Gland Surg. 2021; 9(6):2269-2282.

PMID: 33447579 PMC: 7804546. DOI: 10.21037/gs-20-543.


Ultra-high frequency ultrasound (UHFUS) applications in Sjogren syndrome: narrative review and current concepts.

Aringhieri G, Izzetti R, Vitali S, Ferro F, Gabriele M, Baldini C Gland Surg. 2021; 9(6):2248-2259.

PMID: 33447577 PMC: 7804531. DOI: 10.21037/gs-20-529.


Multimodality advanced imaging and intervention in gland diseases.

Barile A Gland Surg. 2021; 9(6):2211-2214.

PMID: 33447573 PMC: 7804559. DOI: 10.21037/gs-20-592.

References
1.
Jeong S, Kim H, Lee S, Ahn B, Lee J . Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid. 2012; 23(5):609-16. PMC: 3643252. DOI: 10.1089/thy.2012.0106. View

2.
Mandel S, Mandel L . Radioactive iodine and the salivary glands. Thyroid. 2003; 13(3):265-71. DOI: 10.1089/105072503321582060. View

3.
Kim D . Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma. Ultrasound Med Biol. 2015; 41(10):2640-5. DOI: 10.1016/j.ultrasmedbio.2015.06.010. View

4.
Soo Roh S, Kim D, Baek H . Association of Xerostomia and Ultrasonographic Features of the Major Salivary Glands After Radioactive Iodine Ablation for Papillary Thyroid Carcinoma. AJR Am J Roentgenol. 2016; 207(5):1077-1081. DOI: 10.2214/AJR.15.15776. View

5.
Rumboldt Z, Gordon L, Bonsall R, Ackermann S . Imaging in head and neck cancer. Curr Treat Options Oncol. 2005; 7(1):23-34. DOI: 10.1007/s11864-006-0029-2. View